Enzalutamide 40mg tablets
NHS hospitals in England used £393,553,936 of indicative cost of Enzalutamide 40mg tablets in the 12 months to April 2026, about 1.5% of all hospital medicines spend. That is up 2.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Enzalutamide 40mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Enzalutamide 40mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £28,649,808 |
| Oxford University Hospitals Nhs Ft | £13,062,069 |
| Western Sussex Hospitals Nhs Found Trust | £12,148,201 |
| The Clatterbridge Cancer Centre Nhs Ft | £11,328,340 |
| The Royal Marsden Nhs Foundation Trust | £11,298,303 |
| Univ Hpls Bristol Nhs Foundation Trust | £10,319,779 |
| Sheffield Teaching Hospitals Nhs Trust | £9,064,759 |
| Guy's & St Thomas' Nhs Foundation Trust | £8,980,180 |
| Royal Devon & Exeter Nhs Foundation Trst | £8,638,834 |
| Somerset P/Ship Nhs Foundation Trust | £7,583,201 |
The primary-care picture
Enzalutamide is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Enzalutamide medicine page.